Eric Karas
Chief Commercial Officer · 1 filing · Latest: Jun 12, 2026
ARS Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SPRY | ERIC KARAS | — | Oct 1, 2026 | Proposed Sale | $4.26 | 100,000 | $426.1K | — | |
SPRY | ERIC KARAS | — | Sep 30, 2026 | Proposed Sale | $4.32 | 100,000 | $431.6K | — | |
SPRY | ERIC KARAS | — | Sep 11, 2026 | Proposed Sale | $4.96 | 14,064 | $69.8K | — | |
SPRY | Eric Karas | Chief Commercial Officer | Jun 12, 2026 | Sale | $10.00 | 25,000 | $250.0K | 12,176 | |
SPRY | Eric Karas | Chief Commercial Officer | Jun 12, 2026 | Option Exercise | $1.50 | 25,000 | $37.5K | 37,176 | |
SPRY | ERIC KARAS | — | Jun 12, 2026 | Proposed Sale | $10.00 | 25,000 | $250.0K | — | |
SPRY | ERIC KARAS | — | Jul 1, 2025 | Proposed Sale | $16.99 | 15,000 | $254.9K | — | |
SPRY | ERIC KARAS | — | Jun 18, 2025 | Proposed Sale | $16.00 | 15,000 | $240.0K | — | |
SPRY | ERIC KARAS | — | Mar 20, 2025 | Proposed Sale | $14.00 | 10,000 | $140.0K | — | |
SPRY | ERIC KARAS | — | Dec 4, 2024 | Proposed Sale | $14.00 | 6,283 | $88.0K | — | |
SPRY | ERIC KARAS | — | Dec 2, 2024 | Proposed Sale | $14.11 | 3,717 | $52.5K | — | |
SPRY | ERIC KARAS | — | Sep 18, 2024 | Proposed Sale | $14.00 | 10,000 | $140.0K | — |